The LIN28B–IMP1 post-transcriptional regulon has opposing effects on oncogenic signaling in the intestine

Journal: Genes & Development

Published: 2018-08-01

DOI: 10.1101/gad.314369.118

Affiliations: 16

Authors: 18

Go to article
Institutions FC
Division of Gastroenterology (GI), Penn Medicine, United States of America (USA) 0.30
Department of Genetics, RU, United States of America (USA) 0.14
Department of Biology, Penn, United States of America (USA) 0.11
Stanford Division of Hematology, United States of America (USA) 0.06
Department of Molecular Biomedical Sciences (DMBS), NCSU, United States of America (USA) 0.06
Division of Gastroenterology, WUSTL, United States of America (USA) 0.06
Department of Genetics, Penn, United States of America (USA) 0.05
Division of General Pediatrics, CHOP, United States of America (USA) 0.03
Division of Gastroenterology, Hepatology and Nutrition (GI), CHOP, United States of America (USA) 0.03
Perelman School of Medicine, Penn, United States of America (USA) 0.03
Department of Pathology, Temple University, United States of America (USA) 0.03
Fox Chase Cancer Center (FCCC), Temple University, United States of America (USA) 0.03
Department of Biomedical Sciences, Penn Vet, United States of America (USA) 0.03
Institute for Regenerative Medicine (IRM), Penn, United States of America (USA) 0.03
Human Genetics Institute of New Jersey (HGINJ), RU, United States of America (USA) 0.03
Abramson Cancer Center, Penn, United States of America (USA) 0.02

Return